Klotho Neurosciences (KLTOW) Stock Price, News & Analysis

Company Overview

Klotho Neurosciences is a clinical-stage biopharmaceutical company focused on harnessing the biology of the Klotho protein to develop treatments for age-related disorders. The company’s research platform is designed to identify and advance therapeutic candidates—ranging from small molecules and peptides to gene therapy vectors—that upregulate or otherwise modulate Klotho expression. By targeting a protein implicated in neuroprotection, metabolic regulation and tissue homeostasis, the company seeks to address a broad array of neurodegenerative and systemic conditions.

The company’s pipeline includes early-stage programs aimed at enhancing Klotho activity in the central nervous system, with lead assets under evaluation for indications such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and vascular cognitive impairment. These programs leverage a combination of proprietary gene delivery systems, receptor agonists and Klotho gene enhancers discovered through in-house screening efforts and strategic partnerships. Preclinical data have demonstrated improved neuronal survival, reduced inflammation and enhanced synaptic function in animal models.

Founded out of academic research into the aging process, Klotho Neurosciences trades on the Nasdaq under the symbol KLTOW. Headquartered in the United States, the company collaborates with academic institutions, contract research organizations and biotechnology partners to advance its pipeline. Its leadership team comprises executives and scientists with backgrounds in neurology, gene therapy and drug discovery, all united by a goal of translating foundational insights about the Klotho protein into novel, disease-modifying therapies.

Key Stats

• Today's Range: $0.15 to $0.16
• 50-Day Range: $0.13 to $0.28
• 52-Week Range: $0.01 to $0.95
• Volume: 6,865 shs
• Average Volume: 160,342 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KLTOW Stock Analysis - Frequently Asked Questions

How have KLTOW shares performed this year?

Klotho Neurosciences' stock was trading at $0.0462 on January 1st, 2025. Since then, KLTOW shares have increased by 224.9% and is now trading at $0.1501.

How do I buy shares of Klotho Neurosciences?

Shares of KLTOW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:KLTOW
• CIK: 1907223
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A